Information  X 
Enter a valid email address

Ipso Ventures PLC (PPG)

  Print      Mail a friend       Annual reports

Monday 12 July, 2010

Ipso Ventures PLC

Change of Adviser

RNS Number : 1393P
Ipso Ventures PLC
12 July 2010
 



Embargoed for release at 7am                                                                       12 July 2010

 

IPSO Ventures plc

("IPSO" or the "Company")

 

Appointment of nominated adviser and broker

 

IPSO is pleased to announce the appointment of Allenby Capital Limited as its Nominated Adviser and Broker with immediate effect.

 

For further information, please contact:

 

IPSO Ventures plc

Simon Hunt, Executive Chairman

Nick Rodgers, Chief Executive Officer

 

Tel: 020 7921 2990

simon@ipsoventures.com

nick@ipsoventures.com

www.ipsoventures.com

 

Allenby Capital Limited

Nick Naylor

Nick Athanas

 

Tel: 020 3328 5656

n.naylor@allenbycapital.com n.athanas@allenbycapital.com

 



 

Notes for Editors

 

Company description:

 

IPSO creates commercial value from technology and its business model is entirely demand driven.  It works closely with its industrial collaborators to identify the demand for new, innovative technologies and then, through its strong relationships with research institutions, sources technologies which could meet those needs.  Much of this technology requires considerable further work by IPSO before it can be sold to industry as a developed product.  IPSO creates businesses and provides expertise, strategic direction, human and seed capital, as well as corporate finance advice.

 

For industrial collaborators, IPSO provides a mechanism to identify and develop technologies which could be of significant value to their businesses, and removes the risk to them of acquiring raw, unproven and undeveloped technology.

 

For research institutions, IPSO provides greater certainty that their technology will find commercial success.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
APPLLFFVDDIAIII